Cargando…
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)
BACKGROUND: With infertility populations in the developed world rapidly aging, treatment of diminished ovarian reserve (DOR) assumes increasing clinical importance. Dehydroepiandrosterone (DHEA) has been reported to improve pregnancy chances with DOR, and is now utilized by approximately one third o...
Autores principales: | Gleicher, Norbert, Barad, David H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112409/ https://www.ncbi.nlm.nih.gov/pubmed/21586137 http://dx.doi.org/10.1186/1477-7827-9-67 |
Ejemplares similares
-
Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study
por: Gleicher, Norbert, et al.
Publicado: (2009) -
Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)
por: Gleicher, Norbert, et al.
Publicado: (2010) -
Defining ovarian reserve to better understand ovarian aging
por: Gleicher, Norbert, et al.
Publicado: (2011) -
The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women
por: Hu, Qiaofei, et al.
Publicado: (2017) -
Dehydroepiandrosterone (DHEA) Supplementation in Rheumatic Diseases: A Systematic Review
por: Skare, Thelma L., et al.
Publicado: (2023)